Biliary tract cancer

You have access
Pemetrexed and Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer Who Failed Gemcitabine-containing Chemotherapy: A Phase II Single-arm Prospective Study
SUNG HEE LIM, JUNG YONG HONG, JOON OH PARK, YOUNG SUK PARK and SEUNG TAE KIM

Anticancer Research September 2023, 43 (9) 4161-4167; DOI: https://doi.org/10.21873/anticanres.16607
You have access
Epithelial–Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer
CHUNG RYUL OH, HYUNG-DON KIM, YEON-MI RYU, SEONMIN LEE, DANBEE KIM, DA SOL LEE, JAE HO JEONG, HEUNG-MOON CHANG, BAEK-YEOL RYOO, KYU-PYO KIM, MIYEON KIM, SANG-YEOB KIM and CHANGHOON YOO

Anticancer Research February 2023, 43 (2) 645-652; DOI: https://doi.org/10.21873/anticanres.16201
You have access
Efficacy and Feasibility of Adjuvant Gemcitabine Plus Cisplatin Chemotherapy After Major Hepatectomy for Biliary Tract Cancer
SHOZO MORI, TAKU AOKI, TAKAYUKI SHIRAKI, TAKAYUKI SHIMIZU, TAKAMUNE YAMAGUCHI, KYUNG-HWA PARK, TAKATSUGU MATSUMOTO, YUHKI SAKURAOKA, YUKIHIRO ISO and KEIICHI KUBOTA

Anticancer Research October 2021, 41 (10) 5231-5240; DOI: https://doi.org/10.21873/anticanres.15342
You have access
Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection
MASASHI UTSUMI, KOJI KITADA, NAOYUKI TOKUNAGA, YUSUKE YOSHIDA, TORU NARUSAKA, RYOSUKE HAMANO, HIDEAKI MIYASOU, YOUSUKE TSUNEMITSU, SHINYA OTSUKA and MASARU INAGAKI

Anticancer Research April 2021, 41 (4) 2147-2155; DOI: https://doi.org/10.21873/anticanres.14987
You have access
Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer
MUTSUNORI MURAHASHI, TOSHIHISA TSURUTA, KAZUNARI YAMADA, YASUKI HIJIKATA, HISANOBU OGATA, JUNJI KISHIMOTO, SACHIKO YOSHIMURA, TETSURO HIKICHI, YOICHI NAKANISHI and KENZABURO TANI

Anticancer Research March 2021, 41 (3) 1485-1496; DOI: https://doi.org/10.21873/anticanres.14907
You have access
Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow
ALESSANDRO RIZZO, ANGELA DALIA RICCI, NASTASSJA TOBER, MARIA CONCETTA NIGRO, MIRTA MOSCA, ANDREA PALLONI, FRANCESCA ABBATI, GIORGIO FREGA, STEFANIA DE LORENZO, SIMONA TAVOLARI and GIOVANNI BRANDI

Anticancer Research June 2020, 40 (6) 3013-3030; DOI: https://doi.org/10.21873/anticanres.14282
You have access
Preoperative Neutrophil-to-lymphocyte Ratio Predicts Tumor-infiltrating CD8⁺ T Cells in Biliary Tract Cancer
RYOTA TANAKA, KENJIRO KIMURA, SHINPEI EGUCHI, JUN TAUCHI, MASATUNE SHIBUTANI, HIROJI SHINKAWA, GO OHIRA, SADAAKI YAMAZOE, SHOGO TANAKA, RYOSUKE AMANO, HIROAKI TANAKA, MASAKAZU YASHIRO, SHOJI KUBO and MASAICHI OHIRA

Anticancer Research May 2020, 40 (5) 2881-2887; DOI: https://doi.org/10.21873/anticanres.14264
You have access
Aberrant Methylation of Tumor Suppressive miRNAs in Bile from Patients With Pancreaticobiliary Diseases
KOUSHIRO OHTSUBO, KUNIO MIYAKE, SACHIKO ARAI, KOJI FUKUDA, NAOHIRO YANAGIMURA, CHIAKI SUZUKI, SAKIKO OTANI, YUTA ADACHI, AZUSA TANIMOTO, AKIHIRO NISHIYAMA, KANAME YAMASHITA, SHINJI TAKEUCHI, KENJI NOTOHARA, KENICHI YOSHIMURA and SEIJI YANO

Anticancer Research October 2019, 39 (10) 5449-5459; DOI: https://doi.org/10.21873/anticanres.13738
You have access
The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer
NAOHIRO OKANO, AKIYOSHI KASUGA, KIRIO KAWAI, YOSHIYA YAMAUCHI, TAKAAKI KOBAYASHI, DAISUKE NARUGE, FUMIO NAGASHIMA and JUNJI FURUSE

Anticancer Research March 2018, 38 (3) 1755-1761;
You have access
Axitinib for Gemcitabine-refractory Advanced Biliary Tract Cancer: Report of 5 Cases
NAOHIRO OKANO, AKIYOSHI KASUGA, KIRIO KAWAI, TAKAAKI KOBAYASHI, DAISUKE NARUGE, FUMIO NAGASHIMA and JUNJI FURUSE

Anticancer Research July 2017, 37 (7) 3711-3715;

Main menu

User menu

Search

Biliary tract cancer

Pages